Through the regulation of the m6A-GLUT1-mTORC1 axis, METTL3 is actively involved in the proliferation of colorectal cancer, and simultaneous inhibition of mTORC1 and METTL3 has an additive effect on the treatment of colorectal cancer. This evidence concerns the gene SLC2A1 and colorectal cancer.